Cash Flow Symbiotec Pharma Cash flow Statement
Figures in Cr
Standaloned Cash Flow Results
Mar'25
Mar'24
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Symbiotec Pharma
Figures in Cr
standaloned Cash Flow Results
Change(INR)
Change(%)
Profit Before Tax
196.02
444.7
-248.00
-55.92%
Adjustment
29.73
28.8
1.00
3.23%
Changes In working Capital
-107.64
71.6
-178.00
-250.34%
Cash Flow after changes in Working Capital
118.11
545.1
-427.00
-78.33%
Cash Flow from Operating Activities
83.29
438.3
-355.00
-81.00%
Cash Flow from Investing Activities
-291.79
-11.3
-280.00
-2482.21%
Cash Flow from Financing Activities
224.81
-447.9
671.00
150.19%
Net Cash Inflow / Outflow
16.31
-20.9
36.00
178.04%
Opening Cash & Cash Equivalents
6.2
283.8
-277.00
-97.82%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
22.51
262.9
-240.00
-91.44%
Cash Flow - Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is -43.52% vs NA in Mar 2024
Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
83.29
147.46
-43.52%
Footer loading
